Right on the heels of the resurgent auto sector, pharma follows with the second-highest earnings growth of 16 per cent. The US, the largest market in the world for pharma companies, offered mixed results. On the one hand while large companies like Sun Pharma and Dr. Reddy's face increasing heat from the US Food and Drug Administration (USFDA), smaller ones like Alembic and Torrent are doing very well. A stringent USFDA is not Indian pharma's only headache. Domestic sales softened for a number of players. Torrent Pharmaceuticals Blockbuster gains Torrent Pharma tops the pharma sector, with earnings growth of 76 per cent (TTM, YoY). This is higher than even the industry leader Sun Pharma. Torrent has found its calling in following the expiry of rewarding patents of drugs with annual sales worth $1 billion or more. Torrent has